Third Rock Ventures Iii, L.P. is > 10% Shareholder of Neon Therapeutics, Inc.. Currently has a direct ownership of 9.74 Million shares of NTGN, which is worth approximately $30 Million. The most recent transaction as insider was on Jun 29, 2018, when has been sold 9,341,636 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.74M
0% 3M change
0% 12M change
Total Value Held $30 Million

Third Rock Ventures III, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 29 2018
BUY
Conversion of derivative security
-
9,341,636 Added 48.95%
9,741,636 Common Stock

Also insider at

MYOK
MyoKardia Inc
VYGR
Voyager Therapeutics, Inc. Healthcare
FULC
Fulcrum Therapeutics, Inc. Healthcare
RVMD
Revolution Medicines, Inc. Healthcare
PLRX
PLIANT THERAPEUTICS, INC. Healthcare
RLAY
Relay Therapeutics, Inc. Healthcare
NRIX
Nurix Therapeutics, Inc. Healthcare
JNCE
Jounce Therapeutics, Inc. Healthcare
TRV

Third Rock Ventures Iii, L.P.

> 10% Shareholder
Boston, MA

Track Institutional and Insider Activities on NTGN

Follow Neon Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTGN shares.

Notify only if

Insider Trading

Get notified when an Neon Therapeutics, Inc. insider buys or sells NTGN shares.

Notify only if

News

Receive news related to Neon Therapeutics, Inc.

Track Activities on NTGN